Abstract Details

Title Effect of Documentation Patterns on Prevalence of Comorbid Conditions in Ischemic Stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P4 - Poster Session 4 (5:30 PM-6:30 PM)

Poster/Presentation
Number 3-045

Objective

We aim to investigate the impact of changing documentation patterns on prevalence of comorbid conditions in ischemic stroke.

Background

Studies on ischemic stroke over the past decade indicate increasing comorbid conditions, including diabetes, obesity, smoking, atrial fibrillation, hyperlipidemia and hypertension. While these trends might indicate true increase in disease prevalence, better efforts in documentation or coding might account for an apparent increase.

Design/Methods We retrospectively identified patients from the years 2011 and 2017 with acute ischemic stroke aged 18 or older who were hospitalized at a large urban hospital. Medical records of the patients were reviewed for documentation of comorbid conditions in specified section in records, admission history narrative, and discharge diagnoses and narrative in discharge summary. Chi-square test was used to compare the two study periods.

Results One-hundred patients, 50 each from the years 2011 and 2017 were compared. Comparison of 2011 and 2017 years showed only obesity to be lower in prevalence (18% vs 4%, p < 0.003), and other risk factors remained the same: smoking (30% vs 28%, p = 0.793), hypertension (72% vs 74%, p = 0.869), Atrial fibrillation (22% vs 26%, p = 0.564), hyperlipidemia (56% vs 56%, p =1), ischemic heart disease (26% vs 30%, p = 0.593), and diabetes mellitus (38% vs 30%, p = 0.332). There was no statistically significant difference in documentation patterns between the years 2011 and 2017.

Conclusions In our preliminary study, we did not find a significant difference in the documentation patterns between 2011 and 2017. Medical records might reflect the true prevalence of the comorbid conditions of Ischemic stroke.

Authors/Disclosures
Dinesh V. Jillella, MD (Emory University School of Medicine / Grady Memorial Hospital) PRESENTER	Dr. Jillella has nothing to disclose.
Moein Amin, MD (Cleveland Clinic)	Dr. Amin has nothing to disclose.
Shumei Man, MD, PhD (Neurological Institute, Cleveland Clinic)	No disclosure on file
Ken Uchino, MD (Cleveland Clinic Foundation)	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.

��ɫ��

��ɫ��